Formulation of cellulose film containing permeation enhancers for prolonged delivery of propranolol hydrocloride

References

• Walle T, Fagan TC, Conradi EC, et al. Presystemic and systemic glucuronidation of propranolol. Clin Pharmacol Ther 1997;76:167–72
   Google Scholar
• Sawamoto T, Haruta S, Kurosaki Y, et al. Prediction of plasma concentration profile of orally administered drugs based on gastrointestinal transit kinetics and absorbability in rats. J Pharm Pharmacol 1997;49:450–7
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008;26:1261–8
   PubMed Web of Science ®Google Scholar
• Subedi RK, Oh SY, Chun MK, Choi HK. Recent advances in transdermal drug delivery. Arch Pharm Res 2010;33:339–51
   PubMed Web of Science ®Google Scholar
• Ghosh TK, Pfister WR. Transdermal and topical delivery systems: an overview and future trends. Buffalo Grove: Interpharm Press; 1997
   Google Scholar
• Kshirsagar SJ, Bhalekar MR, Mohapatra SK. Development and evaluation of carvedilol-loaded transdermal drug delivery system: in-vitro and in-vivo characterization study. Drug Dev Ind Pharm 2012;38:1530–7
   PubMed Web of Science ®Google Scholar
• Aqil M, Sultana Y, Ali A. Transdermal delivery of beta-blockers. Expert Opin Drug Deliv 2006;3:405–18
   PubMed Web of Science ®Google Scholar
• Verma PRP, Iyer SS. Transdermal delivery of propranolol using mixed grades of eudragit: design and in vitro and in vivo evaluation. Drug Dev Ind Pharm 2000;26:471–6
   PubMed Web of Science ®Google Scholar
• Cilurzo F, Minghetti P, Gennari CG, et al. Formulation study of a patch containing propranolol by design of experiments. Drug Dev Ind Pharm 2014;40:17–22
   Google Scholar
• Fel'dshtein MM, Volchenok VI, Malkhazov LV, et al. Kinetics of propranolol delivery from propercuten transdermal therapeutic systems: in vitro–in vivo correlation. Khim-Farm Zh 1994;28:4–9
   Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603–18
   PubMed Web of Science ®Google Scholar
• Barry BW. Lipid-protien-partitioning theory of skin penetration enhancement. J Control Release 1991;15:237–48
   Web of Science ®Google Scholar
• Lane ME. Skin penetration enhancers. Int J Pharm 2013;447:12–21
   PubMed Web of Science ®Google Scholar
• Mastropietro DJ, Omidian H. Prevalence and trends of cellulosics in pharmaceutical dosage forms. Drug Dev Ind Pharm 2013;39:382–92
   PubMed Web of Science ®Google Scholar
• Luppi B, Bigucci F, Baldini M, et al. Hydroxypropyl methyl cellulose films for prolonged delivery of the antipsychotic drug chlorpromazine. J Pharm Pharmacol 2010;62:305–9
   PubMed Web of Science ®Google Scholar
• Karakatsani M, Dedhiya M, Plakogiannis FM. The effect of permeation enhancers on the viscosity and the release profile of transdermal hydroxypropyl methylcellulose gel formulations containing diltiazem HCl. Drug Dev Ind Pharm 2010;36:1195–206
   PubMed Web of Science ®Google Scholar
• Aungst BJ. Fatty acids as skin permeation enhancers. In: Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. Boca Raton (FL): CRC Press; 1995:277–87
   Google Scholar
• Kim KH, Gwak HS. Effects of vehicles on the percutaneous absorption of donepezil hydrochloride across the excised hairless mouse skin. Drug Dev Ind Pharm 2011;37:1125–30
   PubMed Web of Science ®Google Scholar
• da Silva ER, de Freitas ZMF, de Brito Gitirana L, Ricci-Júnior E. Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention. Drug Dev Ind Pharm 2011;37:569–75
   PubMed Web of Science ®Google Scholar
• Walters KA. Surfactants and percutaneous absorption. In: Scott RC, Guy RH, Hadgraft J, eds. Prediction of percutaneous penetration. London: IBC Technical Services; 1990:148–62
   Google Scholar
• Florence T, Tuker IG, Walters KA. Interaction of non-ionic alkeyl and aryl ethers with membranes and other biological systems. In: Rosen MJ, ed. ACS Symposium Series, 253. Washington, DC: American Chemical Society, 1984:189–207
   Google Scholar
• Som I, Bhatia K, Yasir M. Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci 2012;4:2–9
   PubMedGoogle Scholar
• Sarpotdar PP, Zatz JL. Percutaneous absorption enhancement by nonionic surfactants. Drug Dev Ind Pharm 1986;12:1625–47
   Web of Science ®Google Scholar
• Quiñones OG, Mata Dos Santos HA, Kibwila DM, et al. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2013.809731
   Google Scholar
• Soler LI, Boix A, Lauroba J, et al. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization. Drug Dev Ind Pharm 2012;38:1171–8
   PubMed Web of Science ®Google Scholar
• Choi A, Gang H, Chun I, Gwak H. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin. Int J Pharm 2008;357:126–31
   PubMed Web of Science ®Google Scholar
• Pattnaik S, Swain K, Bindhani A, Mallick S. Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling. Drug Dev Ind Pharm 2011;37:465–74
   PubMed Web of Science ®Google Scholar
• Modamio P, Lastra CF, Mariño EL. A comparative in vitro study of percutaneous penetration of β-blockers in human skin. Int J Pharm 2000;194:249–59
   PubMed Web of Science ®Google Scholar
• Peh KK, Wong C. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharmaceut Sci 1999;2:53–61
   PubMed Web of Science ®Google Scholar
• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101–14
   PubMed Web of Science ®Google Scholar
• Mönkäre J, Hakala RA, Vlasova MA, et al. Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly(epsilon-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivo. J Control Release 2010;146:349–55
   PubMed Web of Science ®Google Scholar
• Hori M, Maiback HI, Guy RH. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro. II: drug, vehicle, and enhancer penetration kinetics. J Pharm Sci 1992;81:330–3
   PubMed Web of Science ®Google Scholar
• Reynold JEF, ed. Martindale: the extra pharmacopoeia. 29th ed. London: The Pharmaceutical Press; 1989
   Google Scholar
• Orienti I, Di Pietra A, Luppi B, Zecchi V. Crosslinked polyvinylalcohol hydrogels as vehicles for hydrophilic drugs. Arch Pharm Pharm Med Chem 2000;333:421–4
   PubMed Web of Science ®Google Scholar